Sector: Health Care
Director information for IQVIA HOLDINGS INC
Board as disclosed in the proxy statement filed February 27, 2026. Titles and roles are as stated in that filing and may have changed since.
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Ari Bousbib | Chairman and CEO, IQVIA; Chairman and Chief Executive Officer | 64 | [] | [] | 2026 |
| Carol J. Burt | Principal, Burt-Hilliard Investments Senior Advisor, Consonance Capital Partners | 68 | ["Chair","Audit Committee Financial Expert"] | ["Audit","N&G","Audit Committee"] | 2026 |
| Colleen A. Goggins | Retired Member of Executive Committee and Worldwide Chair of Consumer Group, Johnson & Johnson; Chair of the Nominating and Governance Committee | 71 | ["Chair"] | ["LDC"] | 2026 |
| James A. Fasano | Retired Managing Director, CPP Investment Board; Chair | 56 | ["Chair","Audit Committee Financial Expert"] | ["N&G","Audit Committee"] | 2026 |
| John G. Danhakl | Managing Partner, Leonard Green & Partners, L.P. | 69 | [] | ["Audit","LDC"] | 2026 |
| John M. Leonard, M.D. | President and Chief Executive Officer, Intellia Therapeutics, Inc. | 68 | ["Audit Committee Financial Expert"] | ["Audit","LDC","Audit Committee"] | 2026 |
| Leslie Wims Morris | Chief Executive Officer, Chase Auto, JP Morgan Chase | 55 | [] | ["Audit"] | 2026 |
| Ronald E. Bruehlman | Executive Vice President and Chief Financial Officer | 65 | [] | [] | 2026 |
| Sheila A. Stamps | Retired Managing Director, Bank of America | 68 | [] | ["Audit"] | 2026 |
| Todd B. Sisitsky | [] | [] | 2026 | ||
| William G. Kaelin Jr., M.D. | Senior Physician-Scientist, Brigham and Women’s Hospital Sidney Farber Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School | 68 | [] | [] | 2026 |
| W. Richard Staub, III | President, Research & Development Solutions | 63 | [] | [] | 2026 |
